Health care startups in Shenzhen, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Hypershell | Shenzhen | Series B | $50.0M | 2026-05-18 |
| MileBot Robotics | Shenzhen | Series B | $14.9M | 2026-08-26 |
| Aibo Medical Robot | Shenzhen | Series A | $14.1M | 2026-10-15 |
| Shanmu SHANMU | Shenzhen | Series A | $14.7M | 2026-05-06 |
| Hongxin Biology | Shenzhen | Series B | $14.0M | 2026-08-13 |
| Artivila Therapeutics | Shenzhen | Series A | $14.7M | 2026-06-23 |
| Edge Medical Robotics | Shenzhen | Series C | $200.0M | 2021-11-05 |
| Supermonkey | Shenzhen | Series E | $15.5M | 2021-05-06 |
8 rows of the CSV in 5 of its 18 columns.
- The 303 health care startups in Shenzhen, China have raised $4.0B in total.
- 58 of them closed their most recent round in the last 12 months, $441.5M combined.
- The largest of those rounds is GeneMind Biosciences' $89.5M Series D, dated September 2026.
- The most recent is PAM2L Biotechnologies' $30.0M Series A on 22 October 2026.
- Shenzhen Capital Group is an investor in 5 of them, more than any other fund.
- Biotech is the most common other sector, with 82 companies (27%).
- 29% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (39% of companies with a recorded size).
- 2 are unicorns, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 303| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
| Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| PulseCare | PulseCare is a medtech company that makes medical devices for cardiac and pan-vascular treatment. | Health care | Series A | $14.0M | 2025-11-06 | $28.1M | Delian Capital, Tasly Capital, Tianfeng Capital | 11 to 50 | 2021 |
| Edge Medical Robotics | Edge Medical Robotics designs, develops, and commercializes surgical robot platforms and medical devices. | Hardware | Series C | $200.0M | 2021-11-05 | $308.0M | Temasek, Mirae Asset Venture Investment, OrbiMed +1 | 11 to 50 | 2017 |
| Supermonkey | Supermonkey develops and operates a mobile app that provides fitness services. | Health care | Series E | $15.5M | 2021-05-06 | CICC, PreAngel, Fosun RZ Capital +1 | 51 to 100 | 2014 | |
| iCarbonX Unicorn | iCarbonX is a China-based company that builds artificial intelligence platforms for health data. | Artificial intelligence | Series A | $45.0M | 2016-07-15 | $200.0M | Share Capital, ProCapital | 51 to 100 | 2015 |
Table 1. Health care startups in Shenzhen, China: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 303.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| 2 | Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| 3 | MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| 4 | Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| 5 | Artivila Therapeutics | Artivila Therapeutics uses artificial intelligence to discover new pharmaceutical drugs for patients. | Artificial intelligence | Series A | $14.7M | 2026-06-23 | $53.3M | Highlight Capital, Med-Fine Capital, Hike Capital +2 | 11 to 50 | 2018 |
| 6 | Shanmu SHANMU | Shanmu develops micro medical robots using digital microfluidic chipsets and artificial intelligence algorithms. | Artificial intelligence | Series A | $14.7M | 2026-05-06 | $16.0M | QF Capital, Hofan Venture, Wanwu Capital +1 | 1 to 10 | 2020 |
| 7 | Aibo Medical Robot | Aibo Medical Robot researches and develops robots for vascular interventional surgery. | Hardware | Series A | $14.1M | 2026-10-15 | $33.0M | Lenovo Capital and Incubator Group (LCIG), CDH Investments, Long Hill Capital +2 | 2020 | |
| 8 | Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
Table 2. Health care startups in Shenzhen, China: the 8 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 5 | 2% | ||
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 3 | 1% | 2 | Aibo Medical Robot, MileBot Robotics |
| 3 | Legend Capital | Venture capital firm | Beijing, China | 3 | 1% | ||
| 4 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 3 | 1% | ||
| 5 | IDG Capital | Private equity firm | Beijing, China | 3 | 1% | ||
| 6 | Share Capital | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | MileBot Robotics |
| 7 | Alwin Capital | Venture capital firm | Beijing, China | 2 | 1% | 1 | Aibo Medical Robot |
| 8 | CDH Investments | Private equity firm | Kowloon City, Hong Kong | 2 | 1% | 1 | Aibo Medical Robot |
| 9 | QF Capital | Private equity firm | Shenzhen, China | 2 | 1% | 1 | Shanmu SHANMU |
| 10 | Haiyuan Capital | Venture capital firm | Shenzhen, China | 2 | 1% | 1 | Hongxin Biology |
| 11 | Vertex Ventures China | Venture capital firm | Beijing, China | 2 | 1% | ||
| 12 | Shanghai Biomedical Industrial Equity Investment Fund | Venture capital firm | Huangpu, China | 2 | 1% | ||
| 13 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 2 | 1% | 1 | Sonosemi Medical |
| 14 | Guangzhou Yuexiu Industrial Investment Fund | Corporate venture arm | Guangzhou, China | 2 | 1% | 1 | Sonosemi Medical |
| 15 | Tasly Capital | Corporate venture arm | Tianjin, China | 2 | 1% |
Table 3. Health care startups in Shenzhen, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 82 | 27% | $2.6B |
| Software | 48 | 16% | $914.8M |
| Hardware | 34 | 11% | $527.9M |
| Artificial intelligence | 28 | 9% | $588.7M |
| Commerce | 8 | 3% | $2.7M |
| Education | 4 | 1% | |
| Energy | 1 | 0% | $600K |
| Cybersecurity | 1 | 0% | |
| Fintech | 1 | 0% |
Table 4. Health care startups in Shenzhen, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Health care startups in Shenzhen, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 2% | |
| October 2026 | 3 | 5% | $44.1M |
| September 2026 | 4 | 7% | $89.5M |
| August 2026 | 7 | 12% | $51.2M |
| July 2026 | 5 | 9% | $28.8M |
| June 2026 | 7 | 12% | $44.3M |
| May 2026 | 4 | 7% | $64.7M |
| April 2026 | 4 | 7% | $43.7M |
| March 2026 | 7 | 12% | $59.3M |
| February 2026 | 3 | 5% | $14.4M |
| January 2026 | 9 | 16% | |
| December 2025 | 3 | 5% | $1.6M |
| November 2025 | 1 | 2% |
Table 6. Health care startups in Shenzhen, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 54 | 18% | $439.9M |
| 2025 | 36 | 12% | $342.2M |
| 2024 | 33 | 11% | $154.3M |
| 2023 | 35 | 12% | $242.1M |
| 2022 | 19 | 6% | $239.1M |
| 2021 | 26 | 9% | $493.9M |
Table 7. Health care startups in Shenzhen, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 28 | 9% |
| 2020 to 2022 | 59 | 20% |
| 2015 to 2019 | 132 | 44% |
| 2010 to 2014 | 53 | 18% |
| Before 2010 | 27 | 9% |
Table 8. Health care startups in Shenzhen, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 26 | 11% |
| 11 to 50 | 94 | 39% |
| 51 to 100 | 58 | 24% |
| 101 to 250 | 30 | 13% |
| 251 to 500 | 14 | 6% |
| 501 to 1,000 | 10 | 4% |
| 1,001 to 5,000 | 5 | 2% |
| 10,001 or more | 2 | 1% |
Table 9. Health care startups in Shenzhen, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its headquarters is in Shenzhen, China. On 16 November 2026 that is 303 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 303 rows: 127 have no round amount, 0 no city and 116 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Shenzhen, China are on the list?
- 303, in the file dated 16 November 2026. 58 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 303 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.